This article chronicles a didactic encounter between an ethics-minded physician-scientist and a personified genome editing technology called clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins, commonly abbreviated as CRISPR/Cas, or simply CRISPR. The interview considers clinically and ethically relevant questions about this technology related to patient safety, therapeutic efficacy, equitable access, and global governance of humanity's genetic legacy.
McConnell, S. C. (2019). An Exclusive Interview With CRISPR. AMA Journal of Ethics, 21(12), E1079–E1088. https://doi.org/10.1001/amajethics.2019.1079